Skip to content

What do treatment as prevention study results mean for treatment?

UK government issues global HIV spending statement

First-line treatment for HIV-2: superior outcomes seen with a boosted protease inhibitor

US approval for hepatitis C drug telaprevir

European approval recommended for hepatitis C drug boceprevir

'Virtual Hospital' a satisfactory and safe way to deliver care to clinically stable HIV-positive patients

Interruption of TB treatment due to drug supply problems common in UK

Further cuts in drug prices make tenofovir more affordable for low-income countries

Moving HIV care is associated with poorer outcomes - many patients not connecting with new clinics